Stay updated on ImPRESS: Losartan Imaging Perfusion Clinical Trial
Sign up to get notified when there's something new on the ImPRESS: Losartan Imaging Perfusion Clinical Trial page.

Latest updates to the ImPRESS: Losartan Imaging Perfusion Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAddition of Revision: v3.4.2 and removal of a general funding/operating status notice; prior Revision: v3.4.1 is also removed. No study details are affected.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding status notice and updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedShow glossary option is now available, and QC metadata has been updated to include Last Update Submitted that Met QC Criteria and Revision: v3.4.0, along with No FEAR Act Data. The previous QC-related labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 have been removed.SummaryDifference0.2%

- Check35 days agoChange DetectedFooter and site-wide navigation updates were added, including Release Notes, policy links, and IPD sharing information. The core study content and user actions on the page remain unchanged.SummaryDifference100%

- Check64 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer.SummaryDifference0.1%

- Check85 days agoChange DetectedA new revision tag, v3.3.2, has been added and the previous tag, v3.3.1, removed. No user-facing content or study details appear to be altered.SummaryDifference0.1%

Stay in the know with updates to ImPRESS: Losartan Imaging Perfusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ImPRESS: Losartan Imaging Perfusion Clinical Trial page.